examples of glp-1 receptor agonists Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review Frontiers | The benefits of

Most GLP-1 Medications Correlated With a Lower Likelihood of Anxiety and Depression Diagnoses

We share the enthusiasm for the real weight loss success experienced by the countless patients taking GLP-1s

Cancer Types Most Studied in Relation to GLP-1 Therapy Current peer-reviewed evidence has focused on the following obesity- and metabolic-related malignancies: Endometrial cancer (consistently demonstrating the strongest protective signal) Ovarian cancer Colorectal cancer Breast cancer (particularly post-menopausal) Meningioma Hepatobiliary cancers (liver and bile duct) Pancreatic cancer Gastric cancer Thyroid cancer Multiple myeloma A Note on Metabolic Dysfunction as the Root of Cancer Predisposition One of the most clinically meaningful insights emerging from the GLP-1 cancer research is the reframing of cancer risk as fundamentally a metabolic problem

DS: Proofreading/correcting manuscript assisting in drawing conclusions from the extracted data